Company · CIK 1674930
Fulgent Genetics, Inc.
| CIK | 1674930 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Incorporated in | DE |
| Business address | CA |
| Listed | FLGT (Nasdaq) |
| First annual or quarterly report | 2016-11-14 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-239964 | 2020-07-21 | 2020-11-20 | 4 | |
| 333-233227 | 2019-08-12 | 2020-08-05 | 7 | |
| 333-213469 | 2016-09-02 | 2016-09-29 | 6 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2020-11-20 | 424B5Shelf takedown | 333-239964 | 0001564590-20-054810 |
| 2020-09-25 | 424B5Shelf takedown | 333-239964 | 0001564590-20-044574 |
| 2020-08-12 | EFFECTDeclared effective | 333-239964 | 9999999995-20-002115 |
| 2020-08-05 | 424B5Shelf takedown | 333-233227 | 0001564590-20-036442 |
| 2020-07-21 | S-3Shelf registered | 333-239964 | 0001564590-20-032816 |
| 2020-05-06 | 424B5Shelf takedown | 333-233227 | 0001564590-20-022036 |
| 2019-11-15 | 424B5Shelf takedown | 333-233227 | 0001564590-19-043574 |
| 2019-11-13 | 424B5Shelf takedown | 333-233227 | 0001564590-19-043275 |
| 2019-08-30 | 424B5Shelf takedown | 333-233227 | 0001564590-19-033797 |
| 2019-08-23 | EFFECTDeclared effective | 333-233227 | 9999999995-19-001958 |
| 2019-08-12 | S-3Shelf registered | 333-233227 | 0001564590-19-031539 |
| 2016-09-29 | 424B4Final prospectus | 333-213469 | 0001193125-16-725686 |
| 2016-09-28 | EFFECTDeclared effective | 333-213469 | 9999999995-16-005807 |
| 2016-09-28 | S-1/AAmendment | 333-213469 | 0001193125-16-722942 |
| 2016-09-26 | S-1/AAmendment | 333-213469 | 0001193125-16-719970 |
| 2016-09-19 | S-1/AAmendment | 333-213469 | 0001193125-16-712712 |
| 2016-09-02 | S-1Registration filed | 333-213469 | 0001193125-16-700733 |
| 2016-06-09 | DRSDraft made public | 377-01334 | 0001564590-16-020423 |